Join to View Full Profile
1 Noaddress LnHollis, NH 03049
Dr. Lager is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Pediatric Hematology/Oncology, 2002 - 2005
University of North Carolina HospitalsResidency, Pediatrics, 1999 - 2001
Duke University School of MedicineClass of 1998
Publications & Presentations
PubMed
- 142 citationsLocal delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models.Christian Hotz, Timothy R. Wagenaar, Friederike Gieseke, Dinesh S. Bangari, Michelle Callahan
Science Translational Medicine. 2021-09-08 - 51 citationsVoxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trialJennifer R. Brown, Mehdi Hamadani, John Hayslip, Ann Janssens, Nina D. Wagner-Johnston
The Lancet. Haematology. 2018-04-01 - 16 citationsPhase I Trial of a Tablet Formulation of Pilaralisib, a Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid TumorsGerald M. Edelman, Jordi Rodon, Joanne Lager, Christelle Castell, Jason Jiang
The Oncologist. 2018-04-01
Press Mentions
NiKang Therapeutics Doses First Patient in a Phase 1/1b Study of NKT3447, an Oral, Selective Inhibitor of CDK2 Which Reduces Cyclin E ExpressionApril 15th, 2024
NiKang Therapeutics Appoints Joanne Lager, M.D., as Chief Medical OfficerJanuary 4th, 2024
iTeos Therapeutics Appoints Joanne Jenkins Lager, M.D., as Chief Medical OfficerMarch 26th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
